Cancer nanomedicines: oversold or underappreciated?
Publication date
2017-01-02
Authors
van der Meel, Roy
Lammers, Twan
Hennink, Wim E.
Editors
Advisors
Supervisors
Document Type
Editorial
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Cancer nanomedicines, Clinical translation, Clinical trials, Combination treatment, Drug delivery, Drug targeting, EPR effect, Triggered release, Taverne, Pharmaceutical Science, Journal Article
Citation
van der Meel, R, Lammers, T & Hennink, W E 2017, 'Cancer nanomedicines : oversold or underappreciated?', Expert Opinion on Drug Delivery, vol. 14, no. 1, pp. 1-5. https://doi.org/10.1080/17425247.2017.1262346